Earlier this month, having already dismissed claims against the individual Irish defendants, Eighth Judicial District Court Judge Mark Denton dismissed the counterclaims against the individual local plaintiffs, leaving only entities in the litigation. Attorneys for both sides tell GlobeSt.com that the case is now shifting from pleadings to discovery.

Generally speaking, the defendants agreed to provide all funds for the development and construction of Sullivan Square in exchange for a 60% interest in the development partnership. GSG's lawsuit contends that Harcourt "conspired to, intended to, and, in fact, did exploit [GSG], obtaining value for the project through [GSG's] efforts, all with the eventually intended result of bankrupting or seriously damaging [GSG] so that [Harcourt] could assume control of the project for their sole benefit."

"Harcourt denies the allegations, saying its commitment to fund was based on being able to obtain construction financing for the project at commercially reasonable terms, terms which became unavailable in 2007 due to the lack of sales and the deteriorating market conditions. In its counterclaim, Harcourt alleges that the plaintiffs and the individuals behind them conspired to lie about the pace of condominium sales and made multiple poor decisions that Harcourt claims cost the project tens of millions of dollars. Specifically, Harcourt claims that GSG entered into an exclusive listing agreement Viridian Group LLC, which Harcourt claims never existed and was a "false front" for GSG principal Ken Smith and his spouse, Dale Rowse.

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.